# Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

> **NCT05919342** · NA · RECRUITING · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 3904 (estimated)

## Conditions studied

- Heart Failure
- Cardiovascular Diseases

## Interventions

- **DIAGNOSTIC_TEST:** NT-proBNP

## Key facts

- **NCT ID:** NCT05919342
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-22
- **Primary completion:** 2024-06-21
- **Final completion:** 2032-12-21
- **Target enrollment:** 3904 (ESTIMATED)
- **Last updated:** 2023-08-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05919342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05919342, "Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05919342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*